Ardent Health Partners, Inc. Common Stock (ARDT)

Ardent Health Partners, Inc. (NYSEARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the fourth quarter and year ended December 31, 2024.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company’s management team will participate in the following investor conferences:

Ardent Health (NYSEARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company’s financial results, discuss recent events and conduct a question-and-answer session.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference being held Jan. 13-16, 2025, in San Francisco.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that seven of its facilities were named among Top Teaching Hospitals and Top Rural Hospitals in the U.S. by The Leapfrog Group. The Leapfrog Top Hospital award is widely acknowledged as one of the most competitive awards American hospitals can receive. The Top Hospital designation is bestowed by The Leapfrog Group, a national watchdog organization of employers and other purchasers known as the toughest standard-setters for health care safety and quality. Top Hospitals will be honored tonight at the 2024 Leapfrog Annual Meeting and Awards Dinner in Washington, D.C.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that nine of its facilities earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 performance measures reflecting errors, accidents, injuries and infections, as well as the systems hospitals have in place to prevent them.

Ardent Health Partners, Inc. (NYSEARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the third quarter ended September 30, 2024.

Ardent Health (NYSEARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that members of the Company’s management team will participate in the following upcoming investor conferences:

Ardent Health (NYSEARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced it will issue its third quarter 2024 results after the market closes on Wednesday, November 6, 2024. A conference call will be held the following day, Thursday, November 7, 2024, at 9:00 a.m. ET to review the Company’s financial results, discuss recent events and conduct a question-and-answer session.

Ardent Health (NYSEARDT) has been added as a member of the broad-market Russell 3000® Index and Russell 2000®, effective Monday, September 23, 2024, as part of the quarterly U.S. Russell Index Initial Public Offering (IPO) update.

Ardent Health (NYSEARDT) today announced it has entered into an amendment to its term loan credit agreement with its lenders to reprice its term loans. The repricing reduces the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 3.25% to Term SOFR plus 2.75%, as well as eliminates the credit spread adjustment. There are no changes to the maturity of the loans following the repricing and all other terms are substantially unchanged. The amended credit agreement is expected to reduce Ardent’s borrowing cost and generate interest expense savings of approximately $5 million annually.

Ardent Health (NYSEARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent’s investor relations program and serve as the primary liaison with investors, analysts and financial partners.

Ardent Health Partners, Inc. (NYSEARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference being held September 4-6, 2024, in New York, NY.

Ardent Health Partners, Inc. (NYSEARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the second quarter ended June 30, 2024.

Ardent Health Partners, Inc. (NYSEARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that it will issue its second quarter 2024 results after the market closes on Wednesday, August 14, 2024. A conference call will be held the following day, Thursday, August 15, 2024, at 10:00 a.m. ET to review the Company’s financial results, discuss recent events and conduct a question-and-answer session.

Ardent Health Partners, Inc. (NYSEARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before deducting underwriting discounts, commissions and other offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase an additional 1,800,000 shares at the public offering price, less underwriting discounts and commissions.